Shire Outlines Case to Investors Against a Deal With AbbVie CHAD BRAY The Irish drug maker said that as an independent company it can more than double its sales in the next seven years to about $10 billion. Shire said it expects double-digit sales growth from its current portfolio of drugs each year. June 23, 2014 at 4:00AM http://nyti.ms/1yEO5ZC The New York Times Business Day Corporate Taxes, Drugs (Pharmaceuticals), Mergers, Acquisitions and Divestitures

By CHAD BRAY via NYT / Eethg. Corps. Inc. / Terrence Herschel G. Business Day http://nyti.ms/1yEO5ZC Shire Outlines Case to Investors Against a Deal With AbbVie June 23, 2014 at 4:00AM The New York Times